International Renal Interest Society chronic kidney disease Stage 1 and acute kidney injury Grade I categorizations of kidney disease are often confused or ignored because patients are nonazotemic and generally asymptomatic. Recent evidence suggests these seemingly disparate conditions may be mechanistically linked and interrelated. Active kidney injury biomarkers have the potential to establish a new understanding for traditional views of chronic kidney disease, including its early identification and possible mediators of its progression, which, if validated, would establish a new and sophisticated paradigm for the understanding and approach to the diagnostic evaluation, and treatment of urinary disease in dogs and cats.
|Original language||English (US)|
|Number of pages||19|
|Journal||Veterinary Clinics of North America - Small Animal Practice|
|State||Published - Nov 1 2016|
Bibliographical noteFunding Information:
Disclosure: Dr L.D. Cowgill has served as a paid consultant for IDEXX Laboratories and CEVA Animal Health . He is a member of the Inernational Renal Interest Society and has received gift funding from IDEXX Laboratories to support his research. Dr J. Elliott has served as a paid consultant for Bayer Animal Health , Boehringer Ingelheim , Elanco Animal Health , Idexx Ltd , CEVA Animal Health, Orion Inc , Nextvet Ltd , and Waltham Centre for Pet Nutrition . He receives research grant funding from CEVA Animal Health, Elanco Animal Health, Zoetis Animal Health , Royal Canin , and Waltham Centre for Pet Nutrition. He is a member of the International Renal Interest Society. Drs D.J. Polzin, M.B. Nabity, G. Segev, G.F. Grauer, S. Brown, C. Langston, and A.M. van Dongen have nothing to disclose.
© 2016 Elsevier Inc.
Copyright 2016 Elsevier B.V., All rights reserved.
- IRIS AKI grade I
- IRIS CKD stage 1
- Kidney biomarkers
- Progressive chronic kidney disease